The New England journal of medicine, 2019-11, Vol.381 (22), p.2103-2113
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
- Ist Teil von
- The New England journal of medicine, 2019-11, Vol.381 (22), p.2103-2113
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
- Beschreibungen/Notizen
- Intravenous valproate, levetiracetam, and fosphenytoin stopped status epilepticus that was resistant to initial treatment with lorazepam in approximately half the patients and did not differ significantly in effectiveness. Hypotension was numerically — but not significantly — more frequent with fosphenytoin.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1905795Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7098487
- Format
- –
- Schlagworte
- Adolescent, Adult, Anticonvulsants, Anticonvulsants - adverse effects, Anticonvulsants - therapeutic use, Arrhythmia, Benzodiazepines, Benzodiazepines - therapeutic use, Child, Child, Preschool, Consciousness, Data collection, Double-Blind Method, Drug dosages, Drug Resistance, Emergency medical care, Enrollments, Epilepsy, Etiracetam, FDA approval, Female, Humans, Hypotension, Hypotension - chemically induced, Infusions, Intravenous, Injections, Intramuscular, Intravenous administration, Intubation, Levetiracetam - adverse effects, Levetiracetam - therapeutic use, Male, Middle Aged, Neurological diseases, Patients, Pharmacists, Phenytoin - adverse effects, Phenytoin - analogs & derivatives, Phenytoin - therapeutic use, Seizures, Status Epilepticus - drug therapy, Teams, Valproic acid, Valproic Acid - adverse effects, Valproic Acid - therapeutic use, Young Adult